The cancer gene therapy industry grows at 19.8% CAGR to US$19.97 billion by 2033, propelled by partnerships and TCR-T expansions. Learn about Europe's 34.5% share, pancreatic cancer focus, and global shifts toward accessible, personalized oncology treatments. https://finance.yahoo.com/news/cancer-gene-therapy-market-size-151300630.html